AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 201 filers reported holding AXSOME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,178,867 | +147920.9% | 30,321 | +27.0% | 0.03% | +13.0% |
| Q1 2023 | $1,472 | -99.8% | 23,868 | +16.0% | 0.02% | +15.0% |
| Q3 2022 | $918,000 | -45.4% | 20,580 | -53.1% | 0.02% | -54.5% |
| Q2 2022 | $1,680,000 | -47.9% | 43,862 | -43.7% | 0.04% | -42.1% |
| Q1 2022 | $3,227,000 | +92.9% | 77,967 | +76.1% | 0.08% | +171.4% |
| Q4 2021 | $1,673,000 | -43.8% | 44,274 | -51.0% | 0.03% | -41.7% |
| Q3 2021 | $2,977,000 | +65.5% | 90,329 | +238.8% | 0.05% | +41.2% |
| Q2 2021 | $1,799,000 | -26.7% | 26,661 | -38.5% | 0.03% | -30.6% |
| Q1 2021 | $2,453,000 | +583.3% | 43,328 | +884.1% | 0.05% | +390.0% |
| Q4 2020 | $359,000 | -62.3% | 4,403 | -67.1% | 0.01% | -75.6% |
| Q3 2020 | $953,000 | +81.5% | 13,381 | +109.8% | 0.04% | +57.7% |
| Q2 2020 | $525,000 | -78.4% | 6,379 | -72.8% | 0.03% | -76.1% |
| Q4 2019 | $2,426,000 | – | 23,473 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |